Quantitative Comparison of HTLV-1 and HIV-1 Cell-to-cell Infection with New Replication Dependent Vectors
Overview
Affiliations
We have developed an efficient method to quantify cell-to-cell infection with single-cycle, replication dependent reporter vectors. This system was used to examine the mechanisms of infection with HTLV-1 and HIV-1 vectors in lymphocyte cell lines. Effector cells transfected with reporter vector, packaging vector, and Env expression plasmid produced virus-like particles that transduced reporter gene activity into cocultured target cells with zero background. Reporter gene expression was detected exclusively in target cells and required an Env-expression plasmid and a viral packaging vector, which provided essential structural and enzymatic proteins for virus replication. Cell-cell fusion did not contribute to infection, as reporter protein was rarely detected in syncytia. Coculture of transfected Jurkat T cells and target Raji/CD4 B cells enhanced HIV-1 infection two fold and HTLV-1 infection ten thousand fold in comparison with cell-free infection of Raji/CD4 cells. Agents that interfere with actin and tubulin polymerization strongly inhibited HTLV-1 and modestly decreased HIV-1 cell-to-cell infection, an indication that cytoskeletal remodeling was more important for HTLV-1 transmission. Time course studies showed that HTLV-1 transmission occurred very rapidly after cell mixing, whereas slower kinetics of HIV-1 coculture infection implies a different mechanism of infectious transmission. HTLV-1 Tax was demonstrated to play an important role in altering cell-cell interactions that enhance virus infection and replication. Interestingly, superantigen-induced synapses between Jurkat cells and Raji/CD4 cells did not enhance infection for either HTLV-1 or HIV-1. In general, the dependence on cell-to-cell infection was determined by the virus, the effector and target cell types, and by the nature of the cell-cell interaction.
Viral Oncogenesis: Synergistic Role of Genome Integration and Persistence.
La Frazia S, Pauciullo S, Zulian V, Garbuglia A Viruses. 2025; 16(12.
PMID: 39772271 PMC: 11728759. DOI: 10.3390/v16121965.
Efficient Genome Editing Using 'NanoMEDIC' AsCas12a-VLPs Produced with Pol II-Transcribed crRNA.
Borovikova S, Shepelev M, Mazurov D, Kruglova N Int J Mol Sci. 2024; 25(23).
PMID: 39684477 PMC: 11641575. DOI: 10.3390/ijms252312768.
Li P, Faraone J, Hsu C, Chamblee M, Liu Y, Zheng Y bioRxiv. 2024; .
PMID: 39605558 PMC: 11601353. DOI: 10.1101/2024.11.12.623078.
A Novel Tax-Responsive Reporter T-Cell Line to Analyze Infection of HTLV-1.
Heym S, Krebs P, Ott K, Donhauser N, Kemeter L, Simon F Pathogens. 2024; 13(11).
PMID: 39599568 PMC: 11597676. DOI: 10.3390/pathogens13111015.
The Assembly of HTLV-1-How Does It Differ from HIV-1?.
Herrmann D, Meng S, Yang H, Mansky L, Saad J Viruses. 2024; 16(10).
PMID: 39459862 PMC: 11512237. DOI: 10.3390/v16101528.